A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma

NCT04502862 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: SAR231893
DRUG: Placebo

Sponsor

Sanofi

Collaborators

[object Object]